HK1130685A1 - Hydrogel suspension and manufacturing process thereof - Google Patents

Hydrogel suspension and manufacturing process thereof

Info

Publication number
HK1130685A1
HK1130685A1 HK09108928.1A HK09108928A HK1130685A1 HK 1130685 A1 HK1130685 A1 HK 1130685A1 HK 09108928 A HK09108928 A HK 09108928A HK 1130685 A1 HK1130685 A1 HK 1130685A1
Authority
HK
Hong Kong
Prior art keywords
manufacturing process
hydrogel suspension
hydrogel
suspension
manufacturing
Prior art date
Application number
HK09108928.1A
Other languages
English (en)
Inventor
Shogo Hiraoka
Takakuni Matsuda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1130685A1 publication Critical patent/HK1130685A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK09108928.1A 2006-05-12 2009-09-28 Hydrogel suspension and manufacturing process thereof HK1130685A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006133914 2006-05-12
PCT/JP2007/060087 WO2007132907A1 (en) 2006-05-12 2007-05-10 Hydrogel suspension and manufacturing process thereof

Publications (1)

Publication Number Publication Date
HK1130685A1 true HK1130685A1 (en) 2010-01-08

Family

ID=38290162

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108928.1A HK1130685A1 (en) 2006-05-12 2009-09-28 Hydrogel suspension and manufacturing process thereof

Country Status (13)

Country Link
US (1) US8617606B2 (xx)
EP (1) EP2018154B1 (xx)
JP (1) JP5203355B2 (xx)
KR (1) KR20090014205A (xx)
CN (1) CN101442986B (xx)
AR (1) AR061087A1 (xx)
AT (1) ATE550014T1 (xx)
AU (1) AU2007250764A1 (xx)
CA (1) CA2649967A1 (xx)
ES (1) ES2381285T3 (xx)
HK (1) HK1130685A1 (xx)
TW (1) TW200808375A (xx)
WO (1) WO2007132907A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415629B (zh) 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
WO2008074853A1 (en) * 2006-12-21 2008-06-26 Novartis Ag Ophthalmic rebamipide solution
DE102010009475B4 (de) * 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
AU2012232062B2 (en) * 2011-03-24 2017-04-20 Otsuka Pharmaceutical Co., Ltd. A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
CN102240260B (zh) * 2011-05-17 2012-05-23 山东省医疗器械研究所 一种治疗阴道干涩症的药物及其制备方法
AR090775A1 (es) * 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
CN104082287B (zh) * 2014-07-25 2016-06-22 孙波 一种纤维素基杀菌乳液的制备方法
MX2020011130A (es) * 2018-04-24 2022-09-09 Shionogi & Co Forma de dosificacion solida que tiene excelente estabilidad.
CN112236146A (zh) * 2018-04-24 2021-01-15 盐野义制药株式会社 稳定性优良的固体制剂
KR101923519B1 (ko) * 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DK0495421T3 (da) 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
JP2808378B2 (ja) * 1991-03-27 1998-10-08 武田薬品工業株式会社 水性懸濁液剤の製造法
CA2083842A1 (en) 1991-03-27 1992-09-28 Hisayuki Nakayama Method for preparation of an aqueous suspension
JPH0616556A (ja) 1992-07-02 1994-01-25 Yoshitomi Pharmaceut Ind Ltd 難溶性薬物含有製剤
JPH0667853A (ja) 1992-08-17 1994-03-11 Hitachi Ltd 除算器
JP2729859B2 (ja) 1993-04-16 1998-03-18 わかもと製薬株式会社 可逆性熱ゲル化水性医薬組成物
HU220864B1 (en) 1993-04-16 2002-06-29 Wakamoto Pharma Co Ltd Reversible, thermally gelling water-base medicinal compositions
AR004214A1 (es) 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
DE19744113A1 (de) 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
US20040063678A1 (en) 1997-10-06 2004-04-01 Bausch & Lomb Incorporated Dexamethasone Gel
DE10044545A1 (de) * 2000-09-05 2002-04-04 Roland Bodmeier Retardpartikeldispersion
EP2591806A1 (en) * 2001-06-14 2013-05-15 Otsuka Pharmaceutical Co., Ltd. Medicinal composition
JP2003095924A (ja) 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液
WO2004050060A1 (ja) * 2002-12-04 2004-06-17 Santen Pharmaceutical Co., Ltd. 結膜下デポによるドラッグデリバリーシステム
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20060258703A1 (en) 2003-07-17 2006-11-16 Ono Pharmaceutical Co., Ltd. Remedy for pruritus comprising piperidine derivative as the active ingredient
JP5382972B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
TW200613006A (en) 2004-09-10 2006-05-01 Otsuka Pharma Co Ltd Rebamipide preparation for rectal administration to be prepared before using
WO2006030851A1 (ja) 2004-09-15 2006-03-23 Santen Pharmaceutical Co., Ltd. ピレノキシン懸濁型点眼剤
TWI363626B (en) * 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TWI415629B (zh) 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
JP5186348B2 (ja) 2008-12-05 2013-04-17 アルファー食品株式会社 膨化米飯食品及びその製造方法

Also Published As

Publication number Publication date
EP2018154B1 (en) 2012-03-21
CN101442986A (zh) 2009-05-27
US8617606B2 (en) 2013-12-31
ATE550014T1 (de) 2012-04-15
US20090148529A1 (en) 2009-06-11
EP2018154A1 (en) 2009-01-28
CN101442986B (zh) 2011-10-05
TW200808375A (en) 2008-02-16
JP2009536940A (ja) 2009-10-22
WO2007132907A1 (en) 2007-11-22
AR061087A1 (es) 2008-08-06
JP5203355B2 (ja) 2013-06-05
CA2649967A1 (en) 2007-11-22
ES2381285T3 (es) 2012-05-24
KR20090014205A (ko) 2009-02-06
AU2007250764A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
HK1130685A1 (en) Hydrogel suspension and manufacturing process thereof
TWI310040B (en) Polymethacrylate and production process thereof
PL1902155T3 (pl) Ciała powlekane materiałem twardym i sposoby ich otrzymywania
EP1934267A4 (en) AQUEOUS LIQUID ABSORPTION AGENT AND PROCESS FOR PRODUCING THE SAME
ZA201001048B (en) Cellulose suspension and method for the production thereof
EP1959417A4 (en) DISPLAY AND DISPLAY MANUFACTURING METHOD
PL2010133T3 (pl) Spienialny żel zawiesinowy
EP2233437A4 (en) NANOFUNCTIONAL SILICA PARTICLES AND METHOD FOR THE PRODUCTION THEREOF
EP2005926A4 (en) ABSORBENT ARTICLE AND MANUFACTURING PROCESS
HK1133188A1 (en) Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
EP2373196A4 (en) VISCOELASTIC BODY SUPPORT AND MANUFACTURING METHOD THEREFOR
EP2030517A4 (en) SWIMSUIT AND MANUFACTURING METHOD THEREFOR
PL1984225T3 (pl) Zawieszenie kół
EP1856711A4 (en) PDP FILTER AND MANUFACTURING METHOD THEREFOR
HK1120660A1 (en) Electrode and manufacturing methods
PL2029812T3 (pl) Pomost i sposób wytwarzania pomostu
EP2061019A4 (en) DISPLAY FILTER AND METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING DISPLAY
IL191065A0 (en) Activated split-polypeptides and methods for their production and use
GB2455474B (en) Industrial absorbents and methods of manufacturing the same
EP2236522A4 (en) CELLULOSE DERIVATIVE AND HYDROGEL THEREOF
ZA200801358B (en) Sol-gel process
EP1967451A4 (en) DEVICE FOR PRODUCING PACKAGING CONTAINER AND PROCESS FOR PRODUCING PACKAGING CONTAINER
HUP0500808A2 (en) Wrapped meat-product and process for production it
EP2086473A4 (en) STENT AND METHOD FOR ITS MANUFACTURE
GB0515625D0 (en) Hydrogel particle

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150510